Former FDA Chiefs Take On Drug Imports; FDA Chief-Nominee Gottlieb Raised Similar Concerns In Past
March 17, 2017
Four former FDA commissioners on Thursday (March 16) urged Congress not to move forward with drug importation, which has been eyed by both President Donald Trump and members of Congress as a drug pricing solution, on the grounds that allowing drug imports would pose safety risks, strain FDA resources and do little to bring down costs. Trump's pick to head FDA also previously said the amount of agency oversight needed to prevent entry of fake drugs would zero out any...
Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting as the Trump administration and congressional Republicans look to their next steps following the collapse of their efforts to repeal and replace.